Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy pill through insurance plans as well as through a cash-pay ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...

Novo Nordisk's Wegovy pill is now available, providing those seeking help with their weight a GLP-1 medicine in a pill for ...

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Novo Nordisk (NVO) downgraded to Hold after FDA GLP-1 actions and 2026 patent cliffs threaten Wegovy supply and growth. See ...

Novo took its message to the people by setting up an exhibit at New York’s Grand Central Terminal. In a major thoroughfare at ...

Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine ...

In December, the FDA approved the once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the US. Manufacturing ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...